Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia
Journal of Clinical Medicine Research
doi 10.14740/jocmr3901
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Elmer Press, Inc.